Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds? (Q45838924)
scientific article
Language:
Current Data About Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?
(P31) (Q13442814)
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P304) 777-780
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P407) (Q1860)

(P433) 6
(P248)
(P932) 2033462
(P813) Friday, November 3, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P478) 34
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P577) Friday, March 1, 1985
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P921) (Q18965147)
(P887)
(P854) https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2033462
(P813) Monday, May 28, 2018

(P1433) (Q864229)
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P1476) "Can ribonucleotide reductase be considered as an effective target for developing antiherpes simplex virus type II (HSV-2) compounds?" (language: en)
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

(P2093) L M Nutter
(P1545) 1
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

S P Grill
(P1545) 2
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

Y C Cheng
(P1545) 3
(P248)
(P698) 2983736
(P813) Saturday, December 16, 2017
(P854) http://europepmc.org/abstract/MED/2983736

other details
description scientific article

External Links
(P356) 10.1016/0006-2952(85)90757-9
(P698) 2983736